<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet href="https://news.x4a.net/wp-content/plugins/pretty-rss-feeds/xslt/pretty-feed.xsl" type="text/xsl" media="screen" ?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>DE.VME</title>
	<atom:link href="https://news.x4a.net/ticker/de-vme/feed/" rel="self" type="application/rss+xml" />
	<link>https://news.x4a.net</link>
	<description></description>
	<lastBuildDate>Tue, 27 Oct 2026 12:55:32 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	
	<item>
		<title>Viromed Medical AG Successfully Completes Capital Increase &#124; $DE.VME</title>
		<link>https://news.x4a.net/marketwire/viromed-medical-ag-successfully-completes-capital-increase-de-vme/</link>
		
		<dc:creator><![CDATA[X4A MarketWire]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 21:57:12 +0000</pubDate>
				<guid isPermaLink="false">https://news.x4a.net/marketwire/viromed-medical-ag-successfully-completes-capital-increase-de-vme/</guid>

					<description><![CDATA[Viromed Medical AG Successfully Completes Capital Increase &#124; $DE.VME]]></description>
										<content:encoded><![CDATA[<p>Viromed Medical AG Successfully Completes Capital Increase | $DE.VME</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Viromed Medical AG resolves to conduct a capital increase through a cash contribution, &#8230;</title>
		<link>https://news.x4a.net/marketwire/viromed-medical-ag-resolves-to-conduct-a-capital-increase-through-a-cash-contribution/</link>
		
		<dc:creator><![CDATA[X4A MarketWire]]></dc:creator>
		<pubDate>Mon, 26 Oct 2026 10:47:24 +0000</pubDate>
				<guid isPermaLink="false">https://news.x4a.net/marketwire/viromed-medical-ag-resolves-to-conduct-a-capital-increase-through-a-cash-contribution/</guid>

					<description><![CDATA[Viromed Medical AG resolves to conduct a capital increase through a cash contribution, excluding shareholders&#8217; subscription rights &#124; $DE.VME]]></description>
										<content:encoded><![CDATA[<p>Viromed Medical AG resolves to conduct a capital increase through a cash contribution, excluding shareholders&#8217; subscription rights | $DE.VME</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>HSV welcomes Viromed Medical GmbH as a new youth development partner</title>
		<link>https://news.x4a.net/marketwire/hsv-welcomes-viromed-medical-gmbh-as-a-new-youth-development-partner/</link>
		
		<dc:creator><![CDATA[X4A MarketWire]]></dc:creator>
		<pubDate>Tue, 06 Oct 2026 06:42:11 +0000</pubDate>
				<guid isPermaLink="false">https://news.x4a.net/?post_type=x4a_wire&#038;p=155</guid>

					<description><![CDATA[HSV welcomes Viromed Medical GmbH as a new youth development partner Viromed Medical GmbH has been supporting the youth teams of HSV since the 2026/27 season. For the 2026/27 season, Hamburger SV is entering into a partnership with Viromed Medical GmbH. The medical technology company will be a partner of HSV&#8217;s youth academy with immediate [&#8230;]]]></description>
										<content:encoded><![CDATA[<p>HSV welcomes Viromed Medical GmbH as a new youth development partner</p>
<p>Viromed Medical GmbH has been supporting the youth teams of HSV since the 2026/27 season.</p>
<p>For the 2026/27 season, Hamburger SV is entering into a partnership with Viromed Medical GmbH. The medical technology company will be a partner of HSV&#8217;s youth academy with immediate effect.</p>
<p>Above all, the company&#8217;s innovation and its strong North German roots are connecting elements to the traditional club. Together, they aim to strengthen the development of young talent and bring about new perspectives.</p>
<p>Michael Scharold, Director of Partnerships and Marketing at HSV , expressed his delight at the merger: &#8220;Viromed stands for the courage to rethink medical solutions while keeping the concrete benefits for people in mind. Especially in youth development, where growth and the future play a daily role, this is an exciting partnership. We are eager to see what impetus will emerge from this new partnership.&#8221;</p>
<p>“We are delighted to welcome Viromed as a partner of HSV’s youth academy. Together, we want to set new standards in the area of ​​youth development and fill the partnership with added value for both Viromed and HSV,” adds Johannes Haupt, Executive Director Team HSV at SPORTFIVE. | $DE.VME</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Viromed Medical AG: Study on cold plasma application in the lung accepted for publicati&#8230;</title>
		<link>https://news.x4a.net/marketwire/viromed-medical-ag-study-on-cold-plasma-application-in-the-lung-accepted-for-publicati-2/</link>
		
		<dc:creator><![CDATA[X4A MarketWire]]></dc:creator>
		<pubDate>Wed, 30 Sep 2026 21:45:39 +0000</pubDate>
				<guid isPermaLink="false">https://news.x4a.net/?post_type=x4a_wire&#038;p=158</guid>

					<description><![CDATA[Viromed Medical AG: Study on cold plasma application in the lung accepted for publication by an internationally leading medical journal &#124; $DE.VME]]></description>
										<content:encoded><![CDATA[<p>Viromed Medical AG: Study on cold plasma application in the lung accepted for publication by an internationally leading medical journal  | $DE.VME</p>
]]></content:encoded>
					
		
		
			</item>
		<item>
		<title>Viromed Medical AG advances product development and market launch in the first half of &#8230;</title>
		<link>https://news.x4a.net/marketwire/viromed-medical-ag-advances-product-development-and-market-launch-in-the-first-half-of/</link>
		
		<dc:creator><![CDATA[X4A MarketWire]]></dc:creator>
		<pubDate>Mon, 28 Sep 2026 06:43:45 +0000</pubDate>
				<guid isPermaLink="false">https://news.x4a.net/?post_type=x4a_wire&#038;p=157</guid>

					<description><![CDATA[Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance &#124; $DE.VME]]></description>
										<content:encoded><![CDATA[<p>Viromed Medical AG advances product development and market launch in the first half of 2026 and confirms full-year guidance | $DE.VME</p>
]]></content:encoded>
					
		
		
			</item>
	</channel>
</rss>
